Brief: AroCell: New Results With TK 210 ELISA Support Early Therapy Response In Breast Cancer

IDL Diagnostics AB (publ)

02/11/2021 12:06

Nov 2 (Reuters) - AroCell AB (publ)  AROC.ST :
    * NEW RESULTS WITH TK 210 ELISA SUPPORT EARLY THERAPY
RESPONSE IN
BREAST CANCER

Source text for Eikon:  ID:nMFN3hmZBc 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))